Semaglutide has rapidly emerged as one of the most transformative medications in the treatment of type 2 diabetes and obesity, with significant benefits for cardiovascular health. A member of the GLP-1 receptor agonist class, Semaglutide mimics the natural hormone glucagon-like peptide-1 (GLP-1) in the body, which plays a vital role https://cancer-second-opinion82692.wikigdia.com/6708888/semaglutide_a_breakthrough_treatment_for_diabetes_weight_loss_and_cardiovascular_health